Back to Search
MORRI MARKOWITZ, MD
MD
Pediatric Gastroenterology Physician
NPI: 1689750523Individual
Specialties, Licenses & Credentials
Pediatrics — Pediatric Gastroenterology
Code: 2080P0206X
126347(NY)
Research & Publications (20)
A randomized trial of calcium supplementation for childhood lead poisoning.
PMID 14702492·Pediatrics·2004
3-trial
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection.
PMID 19648823·J Acquir Immune Defic Syndr·2009
2-rct
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.
PMID 17721395·J Acquir Immune Defic Syndr·2007
4-observational
Long-term efficacy and safety of tipranavir boosted with ritonavir in HIV-1-infected patients failing multiple protease inhibitor regimens: 80-week data from a phase 2 study.
PMID 17554217·J Acquir Immune Defic Syndr·2007
3-trial
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.
PMID 17133211·J Acquir Immune Defic Syndr·2006
4-observational
Induction with abacavir/lamivudine/zidovudine plus efavirenz for 48 weeks followed by 48-week maintenance with abacavir/lamivudine/zidovudine alone in antiretroviral-naive HIV-1-infected patients.
PMID 15980684·J Acquir Immune Defic Syndr·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- CHAM, 3415 BAINBRIDGE AVENUE
BRONX, NY 10467 - Phone
- (718) 741-2450
Quick Facts
- NPI
- 1689750523
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile